<SEC-DOCUMENT>0001193125-18-088058.txt : 20180319
<SEC-HEADER>0001193125-18-088058.hdr.sgml : 20180319
<ACCEPTANCE-DATETIME>20180319172624
ACCESSION NUMBER:		0001193125-18-088058
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20180319
DATE AS OF CHANGE:		20180319
EFFECTIVENESS DATE:		20180319

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INOVIO PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001055726
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330024450
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-223776
		FILM NUMBER:		18699882

	BUSINESS ADDRESS:	
		STREET 1:		10480 WATERIDGE CIRCLE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858 597-6006

	MAIL ADDRESS:	
		STREET 1:		10480 WATERIDGE CIRCLE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INOVIO BIOMEDICAL CORP
		DATE OF NAME CHANGE:	20050404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GENETRONICS BIOMEDICAL CORP
		DATE OF NAME CHANGE:	20011116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GENETRONICS BIOMEDICAL LTD
		DATE OF NAME CHANGE:	19980213
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d464565ds8.htm
<DESCRIPTION>FORM S-8
<TEXT>
<HTML><HEAD>
<TITLE>Form S-8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on March&nbsp;19, 2018 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>
</B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">S-8</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Inovio Pharmaceuticals, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">33-0969592</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>identification no.)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>660 W. Germantown Pike, Suite 110</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Plymouth Meeting, Pennsylvania</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>19462</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2016 Omnibus Incentive Plan </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Full title of plan) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>J.
Joseph Kim, Ph.D. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>President and Chief Executive Officer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Inovio Pharmaceuticals, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>660 W. Germantown Pike, Suite 110 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Plymouth Meeting, Pennsylvania 19462 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(267) <FONT STYLE="white-space:nowrap">440-4200</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, address, including zip code, and telephone number, including area code, of agent for service) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Copy to: </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Brian
F. Leaf, Esq. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Cooley LLP </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>One Freedom Square, Reston Town Center </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>11951 Freedom Drive </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Reston, VA 20190-5640 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Tel: (703) <FONT STYLE="white-space:nowrap">456-8000</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Fax: (703) <FONT STYLE="white-space:nowrap">456-8100</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT>
filer, a smaller reporting company or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company&#148; and &#147;emerging growth company&#148; in Rule <FONT
STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated</FONT> filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;&nbsp;&nbsp;(Do not check if a smaller reporting company)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION
OF REGISTRATION FEE </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title of securities</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>to be registered</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>to be</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>registered
(1)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>maximum</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>offering
price</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>per share(2)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>maximum</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>aggregate</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>offering price(2)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>registration fee</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, $0.001 par value</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">2,000,000 shares</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$4.515</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$9,030,000.00</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$1,124.24</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), this registration statement shall also cover any additional shares of the registrant&#146;s common stock
that become issuable under such plan set forth herein by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration that results in an increase in the number of
outstanding shares of the registrant&#146;s common stock. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Pursuant to Rule 457(c) promulgated under the Securities Act, the proposed maximum aggregate offering price per share and the proposed maximum aggregate offering price were calculated using the average of the high and
low sales prices of Inovio Pharmaceuticals, Inc. common stock on March&nbsp;14, 2018, which is a date within five business days prior to the filing of this registration statement, as reported on the NASDAQ Global Select Market. </TD></TR></TABLE>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXPLANATORY NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> is being filed for the purpose of registering an additional 2,000,000 shares
of common stock of Inovio Pharmaceuticals, Inc. to be issued pursuant to the 2016 Omnibus Incentive Plan. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION REQUIRED IN REGISTRATION STATEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><U>Item&nbsp;3</U>.</TD>
<TD ALIGN="left" VALIGN="top"><U>Incorporation of Documents by Reference</U>. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The contents of the earlier registration statement relating to
the 2016 Omnibus Incentive Plan, previously filed with the Securities and Exchange Commission on February&nbsp;14, 2017 (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-216059),</FONT> are incorporated herein by reference and made a part of this
registration statement. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><U>Item&nbsp;8</U>.</TD>
<TD ALIGN="left" VALIGN="top"><U>Exhibits</U>. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:23.80pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;No.&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:71.40pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center">Description of
Exhibit</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1055726/000119312514277137/d742468dex31.htm">Certificate of Incorporation with all amendments (incorporated by reference to Exhibit 3.1 to the registrant&#146;s registration statement on
 Form <FONT STYLE="white-space:nowrap">S-3(File</FONT> <FONT STYLE="white-space:nowrap">No.&nbsp;333-197584),</FONT> filed on July&nbsp;23, 2014). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1055726/000095012311076829/w84047exv3w2.htm">Amended and Restated Bylaws of Inovio Pharmaceuticals, Inc. dated August&nbsp;
10, 2011 (incorporated by reference to Exhibit 3.2 to the registrant&#146;s current report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on August&nbsp;12, 2011). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1055726/000105572616000036/ino-2016xproxy.htm">Inovio Pharmaceuticals, Inc. 2016 Omnibus Incentive Plan (incorporated by reference to Appendix A to the registrant&#146;s definitive proxy
 statement on Schedule 14A filed on March&nbsp;25, 2016). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1055726/000105572617000013/ino-12312016x10kex1055.htm">Form of Incentive Stock Option Agreement under 2016 Omnibus Incentive Plan (incorporated by reference to Exhibit&nbsp;
10.55 to the registrant&#146;s annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2016 filed on March&nbsp;15, 2017). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1055726/000105572617000013/ino-12312016x10kex1056.htm">Form of Nonqualified Stock Option Agreement under 2016 Omnibus Incentive Plan (incorporated by reference to Exhibit&nbsp;
10.56 to the registrant&#146;s annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2016 filed on March&nbsp;15, 2017). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1055726/000105572617000013/ino-12312016x10kex1054.htm">Form of Restricted Stock Units Award Agreement under 2016 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.54 to the
 registrant&#146;s annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2016 filed on March&nbsp;15, 2017). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;5.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d464565dex51.htm">Opinion of Cooley LLP. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d464565dex231.htm">Consent of independent registered public accounting firm. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d464565dex51.htm">Consent of Cooley LLP (included in Exhibit 5.1). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#sig">Powers of Attorney (included on signature page). </A></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%" VALIGN="top" ALIGN="left"><U>Item&nbsp;9</U>.</TD>
<TD ALIGN="left" VALIGN="top"><U>Undertakings</U>. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned registrant hereby undertakes: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top">To include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">ii.</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To reflect in the prospectus any facts or events arising after the effective date of the registration statement
(or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a </P></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered
would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) if,
in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#147;Calculation of Registration Fee&#148; table in the effective registration statement.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">iii.</TD>
<TD ALIGN="left" VALIGN="top">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;
</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Provided, however</I>, that paragraphs (a)(i) and (a)(ii) do not apply if the information required to be included in a
post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 (the &#147;Exchange Act&#148;) that are
incorporated by reference in the registration statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) That for the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide</I> offering thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the
offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of
the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser,
if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">ii.</TD>
<TD ALIGN="left" VALIGN="top">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">iii.</TD>
<TD ALIGN="left" VALIGN="top">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">iv.</TD>
<TD ALIGN="left" VALIGN="top">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant&#146;s
annual report pursuant to Section&nbsp;13(a) or Section&nbsp;15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#146;s annual report pursuant to Section&nbsp;15(d) of the Exchange Act) that is incorporated by
reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide</I> offering
thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of
the registrant pursuant to the foregoing provisions, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of
any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form <FONT STYLE="white-space:nowrap">S-8</FONT> and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Plymouth Meeting, Pennsylvania, on
March&nbsp;19, 2018. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INOVIO PHARMACEUTICALS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ J. Joseph Kim</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">J. Joseph Kim</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President and Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POWER OF ATTORNEY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Know all persons by these presents, that each person whose signature appears below constitutes and appoints J. Joseph Kim and Peter Kies, and each or either
of them, as such person&#146;s true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, with full power of substitution, for such person, and in such person&#146;s name, place and
stead, in any and all capacities to sign any or all amendments or post-effective amendments to this Registration Statement, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done in
and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that said <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT>
and agents, or any of them or their substitutes, may lawfully do or cause to be done by virtue hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act
of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Signature</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Title</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Date</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Avtar Dhillon</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Avtar Dhillon</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chairman of the Board of Directors</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">March 19, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ J. Joseph Kim</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">J. Joseph Kim</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President, Chief Executive Officer and Director (Principal Executive Officer)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">March 19, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Peter Kies</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Peter Kies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer (Principal Financial and Accounting Officer)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">March 19, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Simon X. Benito</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Simon X. Benito</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">March 19, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ George Bickerstaff</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">George Bickerstaff</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">March&nbsp;19, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Angel Cabrera</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Angel Cabrera</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">March 19, 2018</TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="15%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Signature</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Title</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Date</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Morton Collins</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Morton Collins</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">March 19, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adel A.F. Mahmoud</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Adel A.F. Mahmoud</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">March 19, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Weiner</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">David Weiner</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">March 19, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Wendy Yarno</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Wendy Yarno</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">March 19, 2018</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d464565dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g464565g67i49.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Brian F. Leaf </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(703) <FONT
STYLE="white-space:nowrap">456-8053</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">bleaf@cooley.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;19, 2018 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Inovio Pharmaceuticals, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">660 W. Germantown Pike, Suite 110 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Plymouth Meeting, Pennsylvania
19462 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have represented Inovio Pharmaceuticals, Inc., a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), in connection with the filing by
the Company of a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (the &#147;<B><I>Registration</I></B><B><I> Statement&#148;)</I></B> with the Securities and Exchange Commission covering the offering of up to 2,000,000
shares of the Company&#146;s common stock, par value $0.001 per share (the &#147;<B><I>Shares</I></B>&#148;), pursuant to the Company&#146;s 2016 Omnibus Incentive Plan (the &#147;<B><I>Plan</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with this opinion, we have examined and relied upon (a)&nbsp;the Registration Statement and the related prospectus, (b)&nbsp;the Company&#146;s
Certificate of Incorporation, as amended, and Amended and Restated Bylaws, each as currently in effect, (c)&nbsp;the Plan and (d)&nbsp;the originals or copies certified to our satisfaction of such records, documents, certificates, memoranda and
other instruments as in our judgment are necessary or appropriate to enable us to render the opinion expressed below. We have assumed the genuineness and authenticity of all documents submitted to us as originals, and the conformity to originals of
all documents submitted to us as copies thereof (except that such assumption is not made with respect to the due execution and delivery of documents by the Company). As to certain factual matters, we have relied upon a certificate of officers of the
Company and have not sought to independently verify such matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinion is expressed only with respect to the General Corporation Law of the State
of Delaware. We express no opinion to the extent that any other laws are applicable to the subject matter hereof and express no opinion and provide no assurance as to compliance with any federal or state securities law, rule or regulation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Shares, when sold and issued in accordance with the Plan, and the
Registration Statement and related prospectus, will be validly issued, fully paid and nonassessable (except as to shares issued pursuant to certain deferred payment arrangements, which will be fully paid and nonassessable when such deferred payments
are made in full). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the filing of this opinion as an exhibit to the Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Cooley LLP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian F. Leaf</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Brian F. Leaf</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">ONE FREEDOM SQUARE, RESTON TOWN CENTER, 11951 FREEDOM DRIVE, RESTON, VA 20190-5640&nbsp;&nbsp;T: (703)
456-8000&nbsp;&nbsp;F: (703) 456-8100 &nbsp;&nbsp;WWW.COOLEY.COM </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d464565dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 23.1 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consent of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the incorporation by reference in the Registration Statement (Form <FONT STYLE="white-space:nowrap">S-8)</FONT> pertaining to the 2016 Omnibus
Incentive Plan of Inovio Pharmaceuticals, Inc. of our reports dated March&nbsp;14, 2018, with respect to the consolidated financial statements of Inovio Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of
Inovio Pharmaceuticals, Inc. included in its Annual Report (Form <FONT STYLE="white-space:nowrap">10-K)</FONT> for the year ended December&nbsp;31, 2017, filed with the Securities and Exchange Commission. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Ernst&nbsp;&amp; Young LLP</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">San Diego, California </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;19, 2018 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g464565g67i49.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g464565g67i49.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M%/&U?-<4_P#(OH_]A$/_ $W5/Z4^BS_R<'./^R>Q?_JRRD/^">7_ "1;Q/\
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MI5F[U:V$]C!0;G/G4ITJ.)5",W'_ )<Q<E*:E*7V/_P4%F%Q\#O"-PJE1/\
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M;ZBK/NV16EXL:[K@Y^EXCP/UC"+$P7[W"7;\Z;^-?]NZ2\DI6W/YN^CCQO\
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M\QP[S+#TI5,!B92?U;&86JN:>%K2@I2I5(5HKDDXMX>JJ]&K33G*5+[XUO\
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M/<39]PGF%/-.'LSK97C:=DYTFN6I%-2]G6I34J5>DVDW2K0G!M*\=#Y+O?\
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M\S;]G1A"/,W)IR;;ZF_OK32[&\U*_N(K2PTZTN+Z]NIF$<-K:6D+W%S<2NQ
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; H * "@ H * "@ H * "@ H * "@ H * /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
